Contact Us

No Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Please describe your case:

Date of Incident : 

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic


FDA Warns Antipsychotic Medicine Olanzapine may cause Serious Skin Condition

May 13, 2016
The U.S. Food and Drug Administration (FDA) has issued a warning regarding the antipsychotic medicine olanzapine stating it can cause a "rare but...

Antipsychotic Drugs' Effects On Kids Need More Study, FDA Panel Says

Dec 7, 2009
| Parker Waichman LLP
We’ve been following the issue of prescribing psychotropic drugs to pediatric patients for some time, especially regarding efficacy and safety....

More Worries Over Zyprexa, Seroquel, Other Antipsychotics

Dec 2, 2009
| Parker Waichman LLP
Some antipsychotic medications, including Zyprexa and Seroquel, have been linked to a variety of adverse health reactions including weight gain,...

Atypical Antipsychotics Linked to Worrisome Weight Gains, Other Outcomes, in Children

Oct 28, 2009
| Parker Waichman LLP
Yet another study has linked significant weight gains in children to some antipsychotic medication. Forbes reported that an emerging study found that...

Eli Lilly Reaches Zyprexa Settlement with West Virginia

Aug 21, 2009
| Parker Waichman LLP
Drug maker Eli Lilly has agreed to another multimillion dollar Zyprexa settlement, this time with the state of West Virginia.  According to...

Zyprexa Articles Ghostwritten

Jun 12, 2009
| Parker Waichman LLP
Zyprexa maker Eli Lilly apparently asked doctors to put their names on articles written by company officials in an effort to promote the drug. ...

Alzheimer's Patients on Atypical Antipsychotics Experience "Significant" Weight Gain

Apr 17, 2009
| Parker Waichman LLP
Some newer, atypical, or second-generation, antipsychotic medications have been found to have two serious adverse reactions.  The drugs both...

Eli Lilly Admits Zyprexa Wrongdoing

Jan 23, 2009
| Parker Waichman LLP
Eli Lilly finally admitted some wrongdoing in how it marketed Zyprexa.  Lilly also agreed to pay over $1.4 billion in settlements, but did not...

Atypical Antipsychotic Drugs Double Heart Risks

Jan 15, 2009
| Parker Waichman LLP, LLP
Atypical antipsychotic drugs, including Seroquel, Zyprexa and Risperdal, double the risk of heart failure and death, according to a new study...

Panel Questions Antipsychotics for Kids

Nov 20, 2008
| Parker Waichman LLP
Reuters is reporting that a panel of external experts is urging the U.S. Food and Drug Administration (FDA) and “other U.S. health...

Page 1/8 [first] [prev] 1 2 3 4 5 6 7 8 [next] [last]

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo